Arcutis Biotherapeutics Inc (ARQT)
EBITDA Margin
13.21%
Quarterly · Period ending:
ARQT EBITDA Margin
Latest reported13.21%period ending
Latest reported13.21%period ending
ARQT Quarterly EBITDA Margin (0.00% → 13.21%)
Quarterly ebitda margin
High-resolution chart · PNG
ARQT ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 13.2057% | |
| -5.9508% | |
| 16.5471% | |
| 11.2106% | |
| -14.6643% | |
| -28.3495% | |
| -6.2444% | |
| -75.1045% | |
| -145.2816% | |
| -54.9134% | |
| -429.6318% | |
| -88.6825% | |
| -1,218.8054% | |
| -2,613.9878% | |
| -2,186.9976% | |
| -14,141.7931% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |